IDEAYA Biosciences, Inc. (IDYA) Free cash flow 2017–2025
IDEAYA Biosciences, Inc. (IDYA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$73.5MFY2025 · since FY2017: -$14.0M → -$73.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$73.5M | +70.8% |
| FY2024 | -$251.4M | -113.8% |
| FY2023 | -$117.6M | -29.8% |
| FY2022 | -$90.6M | -55.1% |
| FY2021 | -$58.4M | -206.3% |
| FY2020 | $55.0M | +235.2% |
| FY2019 | -$40.7M | -38.7% |
| FY2018 | -$29.3M | -109.8% |
| FY2017 | -$14.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice